| | N | Group | Alcoholic cirrhosis | NAFLD cirrhosis | value | | N = 280 | N = 105 |
| | Age, years | | 56.91 (48.56, 63.00) | 62.26 (55.71, 67.13) | <0.001 | | Sex, n (%) | Female | 85 (30.4) | 49 (46.7) | 0.004 | | Male | 195 (69.6) | 56 (53.3) | | | Body mass index, (kg/m2) | | 25.96 (23.06, 29.77) | 28.63 (25.34, 34.88) | <0.001 | | Obese, n (%) | | 68 (24.3) | 44 (41.9) | 0.001 | | Mid-arm circumference (cm) | | 26.00 (23.00, 29.00) | 29.00 (25.00, 33.00) | <0.001 | | Tricipital skinfold (mm) | | 9.00 (6.20, 15.10) | 14.00 (7.80, 21.40) | <0.001 | | Mid-arm muscle area (cm2) | | 40.23 (33.01, 48.31) | 43.92 (35.25, 57.90) | 0.002 | | Hand grip strength (kg) | | 22.55 (15.88, 29.85) | 23.13 (15.83, 29.86) | 0.945 | | Low hand grip strength, n (%) | | 198 (70.7) | 67 (63.8) | 0.217 | | Chair stands (s) | | 0.36 (0.27, 0.43) | 0.39 (0.30, 0.48) | 0.167 | | Chair stands categories, n (%) | Normal | 23 (8.2) | 16 (15.2) | 0.133 | | Low | 159 (56.8) | 57 (54.3) | | Unable to stand | 98 (35.0) | 32 (30.5) | | Equilibrum total time (s) | | 30.00 (20.00, 30.00) | 30.00 (24.58, 30.00) | 0.143 | | Equilibrum categories, n (%) | Normal | 165 (58.9) | 68 (64.8) | 0.498 | | Low | 77 (27.5) | 27 (25.7) | | Unable to stand | 38 (13.6) | 10 (9.5) | | Liver frailty index (LFI) | | 4.48 (3.97, 5.04) | 4.28 (3.81, 4.87) | 0.061 | | Frailty, LFI > 80th percentile, n (%) | | 60 (21.4) | 14 (13.3) | 0.082 | | Frailty, LFI > 4, 5 | | 134 (47.9) | 50 (47.6) | 1.00 | | Serum bilirubin (umol/l) | | 50.0 (26.51, 137.05) | 26.2 (18.8, 76.75) | <0.001 | | Serum albumin (g/l) | | 28.90 (24.00, 33.00) | 29.00 (27.00, 35.00) | 0.018 | | Serum creatinine (umol/l) | | 77.90 (59.00, 113.00) | 79.00 (63.00, 113.00) | 0.868 | | C-reactive protein (mg/l) | | 16.23 (6.94, 40.20) | 10.84 (4.99, 22.79) | 0.010 | | White blood cells (109/l) | | 7.20 (4.88, 11.03) | 5.80 (3.80, 7.50) | <0.001 | | MELD-Na score | | 18.91 (14.00, 24.00) | 15.00 (11.00, 19.00) | <0.001 | | Child-Pugh-Turcotte score | | 10.00 (7.00, 11.00) | 8.00 (7.00, 10.00) | <0.001 | | Hepatocellular carcinoma, n (%) | | 19 (6.8) | 18 (17.1) | 0.002 | | Refractory ascites, n (%) | | 89 (33.1) | 23 (22.3) | 0.044 | | Number connection test, n (%) | Normal | 37 (13.2) | 13 (12.4) | 0.778 | | 60–90 | 69 (24.6) | 28 (26.7) | | 90–120 | 70 (25.0) | 29 (27.6) | | >120 | 83 (29.6) | 25 (23.8) | | Not done | 21 (7.5) | 10 (9.5) | | Event during follow-up, n (%) | None, LT, death | 145, 14, 121 (51.8, 5.0, 43.2) | 52, 7, 46 (49.5, 6.7, 43.8) | 0.771 | | Mortality | 30 days | 40 (14.3) | 14 (13.3) | 0.87 | | 90 days | 75 (26.8) | 29 (27.6) | 0.898 | | 180 days | 106 (37.9) | 37 (35.2) | 0.723 |
|
|
